As per estimates, the anti-counterfeit pharmaceutical packaging market is anticipated to reach a valuation of US$ 108.1 billion in 2023. Projected growth indicates that by 2033, this market is poised to expand significantly, with an expected value of US$ 246.6 billion, showcasing a Compound Annual Growth Rate (CAGR) of 8.6%. The escalating demand for robust authentication measures in pharmaceutical packaging is a primary driver fueling this growth trajectory. As regulatory pressures mount and the need for secure supply chains intensifies, the market for anti-counterfeit pharmaceutical packaging solutions is positioned for substantial advancement over the forecasted period.
The increasing emergence of new anti-counterfeiting technologies, such as edible micro tags can only be scanned through the utilization of the manufacturer’s proprietary equipment. It is also helping expand the global anti-counterfeit pharmaceutical packaging market.
Germany’s position as a leader in innovation and technology plays a pivotal role in the expected growth of the anti-counterfeit pharmaceutical packaging industry. With a projected market value of US$ 148.6 billion in 2023, Germany’s pharmaceutical packaging sector is set to thrive. This growth is primarily attributed to the nation’s robust commitment to technological advancements and its reputation for pioneering cutting-edge solutions.
Request Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-2385
The increasing prevalence of counterfeit pharmaceuticals poses a significant threat to public health. As awareness of this issue grows, pharmaceutical companies and regulatory bodies are taking strong measures to combat counterfeiting. It is done through advanced packaging solutions, which in turn drives the demand for anti-counterfeit pharmaceutical packaging.
Continuous advancements in anti-counterfeit technologies have made it feasible and cost-effective for pharmaceutical companies to implement robust security measures. Increasing strict regulation by governments and regulatory agencies for pharmaceutical packaging is likely to drive the market throughout the forecast period.
The growth of online pharmaceutical sales and e-commerce platforms has made it easy for counterfeit drugs to enter the market. E-commerce platforms are adopting anti-counterfeit packaging to protect consumers. The pharmaceutical industry’s continued growth and expansion into emerging markets are driving the need for anti-counterfeit measures.
Key Takeaways
- From 2018 to 2022, the anti-counterfeit pharmaceutical packaging market demand expanded at a CAGR of 6%
- Based on printing technology, the RFID segment is expected to account for a market share of 7.8% during the forecast period.
- Global anti-counterfeit pharmaceutical packaging demand in the United Kingdom is predicted to account for a CAGR of 8.4% through 2033.
- In the United States, the market is expected to account for a CAGR of 8.5% between 2023 and 2033.
- China is projected to expand by a value CAGR of 8.3% through 2033.
- By 2033, India’s anti-counterfeit pharmaceutical packaging market is anticipated to record a CAGR of 8.0%.
“The increasing consumer awareness and expansion of the pharmaceutical industry globally is anticipated to drive the market growth during the forecast period.” says an FMI analyst.
Competitive Landscape
Leading anti-counterfeit pharmaceutical packaging manufacturers increasingly focus on expanding their product offerings to strengthen their customer base. They are adopting growth strategies such as new product launches, partnerships, acquisitions, mergers, collaborations, etc. They expand their global footprint and gain a competitive edge in the market by following these strategies.
Some pharma companies have set up departments whose primary function is safeguarding their brand name from counterfeiting and illicit replication, raising the demand for anti-counterfeit pharmaceutical packaging.
- IBM has been exploring the use of blockchain technology in pharmaceutical supply chains. They have collaborated with various pharmaceutical companies and regulatory bodies to create transparent and secure systems for tracking the provenance of pharmaceutical products
- Systech offers serialization and traceability solutions for pharmaceutical companies. Their platform helps pharmaceutical manufacturers comply with track-and-trace regulations and provides real-time visibility into the supply chain.
- Optel Group provides traceability and serialization solutions for the pharmaceutical industry. They have actively implemented track-and-trace systems to prevent counterfeit drugs from entering the supply chain.
Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-2385
Market Drivers:
- Regulatory Compliance: Stringent regulations imposed by regulatory bodies such as the FDA (Food and Drug Administration) and the European Medicines Agency (EMA) to curb counterfeit drugs are driving pharmaceutical companies to adopt anti-counterfeit packaging solutions.
- Increasing Counterfeit Activities: Rising incidents of counterfeit pharmaceuticals entering the supply chain have necessitated the implementation of robust anti-counterfeit measures to protect consumers and brand reputation.
- Technological Advancements: Continuous advancements in printing technologies, serialization, RFID (Radio Frequency Identification), and track-and-trace systems enable pharmaceutical companies to implement sophisticated anti-counterfeit packaging solutions.
- Consumer Awareness: Growing awareness among consumers regarding the risks associated with counterfeit drugs and the importance of authentic pharmaceutical products is pushing pharmaceutical companies to invest in anti-counterfeit measures to gain consumer trust.
- Brand Protection: Pharmaceutical companies are increasingly recognizing the importance of safeguarding their brands against counterfeit products, which can not only cause financial losses but also pose significant health risks to consumers.
- Globalization of Pharmaceutical Supply Chains: With the globalization of pharmaceutical supply chains, there’s a greater need for secure packaging solutions to ensure the integrity and authenticity of products as they move across borders.
Market Restraints:
- Cost Implications: Implementing anti-counterfeit measures can involve significant upfront costs for pharmaceutical companies, including investment in specialized equipment, technology, and ongoing maintenance expenses.
- Complexity of Implementation: Integrating anti-counterfeit packaging solutions into existing supply chain processes can be complex and time-consuming, requiring coordination among multiple stakeholders and adherence to regulatory requirements.
- Potential for Over-Regulation: Excessive regulation in some regions may create challenges for pharmaceutical companies, leading to compliance burdens and operational inefficiencies, which could hinder market growth.
- Technological Limitations: Despite advancements, certain anti-counterfeit technologies may still have limitations in terms of effectiveness, scalability, or compatibility with existing packaging formats, posing challenges for widespread adoption.
- Resistance from Counterfeiters: Sophisticated counterfeiters may continually evolve their tactics to circumvent anti-counterfeit measures, necessitating ongoing innovation and investment from pharmaceutical companies to stay ahead.
- Supply Chain Disruptions: Implementation of new anti-counterfeit packaging solutions could potentially disrupt existing supply chain processes, leading to temporary slowdowns or inefficiencies until systems are fully integrated and optimized.
Some of the key players in the global anti-counterfeit pharmaceutical packaging market are
- Alien Technology
- ATL Security Label Systems
- CCL Industries
- SICPA Holdings
- Schott AG
- Gerresheimer AG
- Klockner Pentaplast Group
- Ardagh Group S.A.
- Nipro Corporation
- Authentix Inc.
- TruTag Technologies Inc.
- Zebra Technologies Corporation
- Alpvision SA
- OpSec Security Inc.
- Savi Technology Inc.
- 3M
- Stevanato Group.
Buy Now/Purchase: https://www.futuremarketinsights.com/checkout/2385
Key Segmentations:
By Packaging Format :
- Bottles & Jars
- Vials & Ampoules
- Blisters
- Trays
- Pouches & Sachets
- Others (Tubes, Syringes, etc.)
By Printing Technology :
- RFID
- Security Inks & Coatings
- Security Seals
- Holograms
- Mass Encryption
- Barcode
- Mass Serialization
By Adhesion :
- Permanent
- Removable
- Repositionable
By End-application :
- Pharma & Biological
- Medical & Supplies
- Gloves
- Scissors
- Syringes & Needles
- Surgical Tapes
- Others
- Medical Equipment
- Surgical
- Therapeutic
- Diagnostic
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
